Table 1 Demographics and clinical pre-operative characteristics of the study groups.
From: Topical insulin in neurotrophic keratopathy after diabetic vitrectomy
Control group (n. 18 eyes) | Study group (n. 19 eyes) | P value | |
|---|---|---|---|
Age | 52.5 ± 10.7 | 49.3 ± 8.6 | 0.30 |
Gender | |||
Male | 10 | 11 | 0.57 |
Female | 8 | 8 | |
DM type | |||
Type 1 | 2 | 2 | 0.67 |
Type 2 | 16 | 17 | |
HBA1c | 8.5 ± 1.6 | 8.4 ± 1.05 | 0.82 |
Indication of vitrectomy | |||
Advanced diabetic retinopathy | 7 | 8 | 0.52 |
Tractional retinal detachment | 5 | 4 | |
Vitreous hemorrhage | 6 | 7 | |
Silicone tamponade | 14 | 13 | 0.19 |
Endolaser panretinal photocoagulation | 100% | 100% | 1.0 |
Time till NK diagnosis (days) | 10.6 ± 4.3 | 11.9 ± 4.5 | 0.63 |
NK stage | |||
2 | 15 | 14 | 0.98 |
3 | 3 | 5 | |
